Performance evaluation of a point of care cartridge of the new GEM Premier ChemSTAT analyzer.

Acute kidney injury Blood urea nitrogen Chemistry panel Creatinine Estimated glomerular filtration rate Point-of-care

Journal

Practical laboratory medicine
ISSN: 2352-5517
Titre abrégé: Pract Lab Med
Pays: Netherlands
ID NLM: 101690848

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 24 09 2021
revised: 01 07 2022
accepted: 15 07 2022
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

GEM Premier ChemSTAT is a new point-of-care system providing rapid creatinine, BUN and tCO Heparinized whole blood samples from different clinical locations were evaluated on the GEM Premier ChemSTAT and results compared to plasma from the same samples on the Beckman AU5800 or whole blood on the GEM Premier 4000. Precision studies were conducted with whole blood and quality control material. ChemSTAT correlated well with plasma samples on the AU5800 (regression slopes (S): 0.957-1.159, correlation coefficients (r)≥0.952) and with whole blood specimens on the GEM Premier 4000 (S: 0.9646-1.124, r ≥ 0.974). The repeatability was 0.1%-3.1% and QC precision were within lab and manufacturers' specifications. ChemSTAT demonstrated strong correlation to the comparative methods and excellent precision. Combining with its continuous quality management, ChemSTAT is suitable for acute care settings to provide rapid, reliable results, which could minimize time-to-treatment and improve patient outcome.

Sections du résumé

Background and aims UNASSIGNED
GEM Premier ChemSTAT is a new point-of-care system providing rapid creatinine, BUN and tCO
Materials and methods UNASSIGNED
Heparinized whole blood samples from different clinical locations were evaluated on the GEM Premier ChemSTAT and results compared to plasma from the same samples on the Beckman AU5800 or whole blood on the GEM Premier 4000. Precision studies were conducted with whole blood and quality control material.
Results UNASSIGNED
ChemSTAT correlated well with plasma samples on the AU5800 (regression slopes (S): 0.957-1.159, correlation coefficients (r)≥0.952) and with whole blood specimens on the GEM Premier 4000 (S: 0.9646-1.124, r ≥ 0.974). The repeatability was 0.1%-3.1% and QC precision were within lab and manufacturers' specifications.
Conclusion UNASSIGNED
ChemSTAT demonstrated strong correlation to the comparative methods and excellent precision. Combining with its continuous quality management, ChemSTAT is suitable for acute care settings to provide rapid, reliable results, which could minimize time-to-treatment and improve patient outcome.

Identifiants

pubmed: 35880117
doi: 10.1016/j.plabm.2022.e00297
pii: S2352-5517(22)00036-1
pmc: PMC9307927
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e00297

Informations de copyright

© 2022 The Authors. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

AEG, RB, MM, RF and EC declare no potential conflicts of interest concerning the research, authorship, and/or publication of this article. CX declares employment by Werfen.

Références

J Med Virol. 2020 Nov;92(11):2616-2622
pubmed: 32470186
Clin Chem. 2006 Jan;52(1):5-18
pubmed: 16332993
Am J Emerg Med. 2021 Jul;45:345-351
pubmed: 33046291
Am J Emerg Med. 2021 May;43:149-157
pubmed: 33046323
J Appl Lab Med. 2019 Sep;4(2):180-192
pubmed: 31639663

Auteurs

Alba E García-Fernández (AE)

Clinical Laboratories, Vall d'Hebron Hospital Campus, Barcelona, Spain.

Raquel Barquín (R)

Clinical Laboratories, Vall d'Hebron Hospital Campus, Barcelona, Spain.

Mariano Martínez (M)

Clinical Laboratories, Vall d'Hebron Hospital Campus, Barcelona, Spain.

Roser Ferrer (R)

Clinical Laboratories, Vall d'Hebron Hospital Campus, Barcelona, Spain.

Ernesto Casis (E)

Clinical Laboratories, Vall d'Hebron Hospital Campus, Barcelona, Spain.

Clarke Xu (C)

Werfen, Bedford, MA, USA.

Classifications MeSH